Bal Harbour, Fla. - The use of topically applied immune response modifier imiquimod (Aldara) goes beyond its FDA-approved application for the treatment of genital and perianal warts.
Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised
Managing Food Allergies with Dupilumab in Pediatric Dermatology